Pharmaceutical Nanotechnology: Revolutionizing Drug Delivery and Therapeutics
Keywords:
Pharmaceutical nanotechnology, drug delivery, nanoparticles, liposomes, targeted therapy, personalized medicine, safetyAbstract
Pharmaceutical nanotechnology is an emerging field that encompasses the design, development, and application of nanoscale materials and devices for drug delivery and therapeutics. Nanotechnology offers numerous advantages in the pharmaceutical industry, including enhanced drug solubility, improved bioavailability, targeted drug delivery, and reduced side effects. This review paper provides an in-depth analysis of the key concepts, recent advancements, challenges, and future prospects in pharmaceutical nanotechnology. The discussion highlights various nanoparticulate systems, such as liposomes, nanoparticles, and nanosuspensions, as well as their applications in improving drug stability, release profiles, and targeting specific sites. Moreover, regulatory considerations and ethical implications surrounding nanotechnology-based pharmaceuticals are also explored. The review concludes by emphasizing the transformative potential of pharmaceutical nanotechnology in shaping the future of medicine and healthcare.
How to cite this article:
Patil P, singh A. Pharmaceutical Nanotechnology: Revolutionizing Drug Delivery and Therapeutics. Rec Trends Pharm Tech Ind 2023; 5(1): 11-13.
References
Torchilin V P. (Ed). Handbook of Nanobiomedical Research: Fundamentals, Applications, and Recent Developments. Pan Stanford 2013;.
Farokhzad O C, Langer R. Impact of Nanotechnology on Drug Delivery. ACS Nano, 2009; 3(1):, 16-20.
Mitragotri S, Lahann J. Physical approaches to biomaterial design. Nature Materials, 2009; 8(1):, 15-23.
Davis M E, Chen Z G, Shin D M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug Discovery, 2008; 7(9):, 771-782.
Peer D, Karp J M, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2007; 2(12):, 751-760.
Etheridge M L, Campbell S A, Erdman A G, et al. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine: Nanotechnology, Biology and Medicine, 2013; 9(1):, 1-14.
Pridgen E M, Alexis F, Kuo T T, et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Science Translational Medicine, 2014; 6(213), 213ra167.
Chauhan V P, Jain R K. Strategies for advancing cancer nanomedicine. Nature Materials, 2013; 12(11):, 958- 962.
De Jong W H, Borm P J. Drug delivery and nanoparticles: applications and hazards. International Journal of Nanomedicine, 2008; 3(2):, 133-149.
Hua S, Wu S Y. The use of lipid-based nanocarriers for targeted pain therapies. Frontiers in Pharmacology, 2013; 4:, 143.
Jain K K. (Ed.). Applications of Nanobiotechnology for Drug Delivery. Springer Science & Business Media 2008;.
Prabhakar U, Maeda H, Jain R K, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Research, 2013; 73(8):, 2412-2417.
Sahoo S K, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discovery Today, 2003; 8(24):, 1112-1120.
Lammers T, Kiessling F, Hennink W E, et al. Nanoparticlebased drug delivery to tumors: principles, progress, and prospects. Annual Review of Pharmacology and Toxicology, 2012; 52, 379-406.
Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnology, 2015; 33(9):, 941-951.
